Most importantly: Survival analyses for both T2D and obese/overweight participants determined that NAION may have the greatest risk of developing within the first year of starting semaglutide prescription use

Contact your healthcare provider if you experience: Absent periods (amenorrhea): Missing three or more consecutive menstrual cycles if previously regular, or six or more months if previously irregular Heavy bleeding (menorrhagia): Soaking through a pad or tampon every hour for several consecutive hours, or periods lasting longer than seven days Severe pain: New or worsening menstrual cramping not relieved by over-the-counter medications Intermenstrual bleeding: Bleeding or spotting between periods that persists beyond initial treatment months Pregnancy possibility: Any missed period when pregnancy is possible, as tirzepatide is not recommended during pregnancy Urgent warning signs: Heavy bleeding with dizziness, fainting, rapid heartbeat, or severe weakness requires emergency evaluation Your healthcare provider may recommend specific investigations to evaluate persistent menstrual irregularities

While the exact mechanism linking semaglutide to NAION is not fully understood, Kopelman told MNT , there are a few theories. He explained that semaglutide may influence vascular health and blood flow, potentially contributing to ischemic events in predisposed individuals. An ischemic event is when an organ or tissue does not receive adequate blood, and therefore oxygen
Comparing Oral, Sublingual, and Injectable Efficacy Vitamin B12 comes in oral, sublingual, and injectable forms